PROSTHETIC VALVE CARDIOBACTERIUM HOMINIS ENDOCARDITIS IN A PATIENT WITH HYPERCOAGULABILITY: TO ANTICOAGULATE OR NOT TO ANTICOAGULATE  by Bhimani, Natasha et al.
FIT Clinical Decision Making
A585
JACC March 17, 2015
Volume 65, Issue 10S
prOStHetic ValVe cardiOBacteriuM HOMiniS endOcarditiS in a patient witH 
HypercOagulaBility: tO anticOagulate Or nOt tO anticOagulate
Moderated Poster Contributions
Pulmonary Hypertension and FIT Clinical Decision Making Moderated Poster Theater, Poster Hall B1
Sunday, March 15, 2015, 3:45 p.m.-3:55 p.m.
Session Title: FIT Clinical Decision Making: Moderated Poster Session III
Abstract Category: Valvular Heart Disease
Presentation Number: 1234M-03
Authors: Natasha Bhimani, Jatan Shah, Michael Simms, St. Mary’s Hospital, Waterbury, CT, USA
Background:  Cardiobacterium hominis (C. hominis) is an uncommon cause of endocarditis and often presents insidiously, making the 
diagnosis difficult. On the other hand, prosthetic valve thrombosis (PVT) is a rare, but life-threatening condition that commonly occurs due 
to inadequate anticoagulation. Anticoagulation is contraindicated in patients with endocarditis as it may prove to be lethal due to increased 
risk of hemorrhagic stroke whereas it is required in PVT.
case:  A 35-year-old African American male with a history of hypercoagulability with deep vein thrombosis, pulmonary embolism, arterial 
thrombus and prosthetic aortic valve presented with a two-day history of dyspnea and pleuritic chest pain. Home medications included 
warfarin, carvedilol and oxycodone. Vital signs were stable on admission. Physical exam was remarkable for a chronic II/VI systolic murmur 
throughout the precordium. Laboratory studies were unremarkable, except sub-therapeutic INR of 1.5.
decision Making:  CT chest obtained to rule out pulmonary embolism showed thickening of aortic valve. Transthoracic echocardiogram 
(TTE) showed an echo-dense mass on the aortic valve highly suspicious for a thrombus. Due to a high suspicion for PVT, heparin was 
initiated and warfarin dose was increased with an INR goal between 2.5-3.5. Blood cultures were obtained to exclude subacute bacterial 
endocarditis (SBE) and were positive for C. hominis three days after. The patient was started on appropriate antibiotic and treated for six 
weeks following negative culture results.
conclusion:  In the absence of classical stigmata of endocarditis, presence of sub-therapeutic INR, mass on the aortic valve as seen in 
the TTE, and patient’s underlying hypercoagulability, the possibility of PVT was very high and anticoagulation was immediately indicated. 
However, with positive blood cultures, SBE also became likely and this posed as a management dilemma. In our patient, due to the 
complexity of his case, he was continued on both anticoagulation and antibiotic treatment. This case demonstrates the importance of 
weighing the risks and benefits and managing appropriately as SBE and PVT may both be fatal if left untreated.
